April 21, 2020

FDA Authorizes First COVID-19 Test for At-Home Sample Collection

The FDA issued an emergency use authorization (EUA) for LabCorp’s COVID-19 RT-PCR test to permit testing of samples self-collected by patients at home using a special home collection kit.

Headlines surrounding this development have confused the public into believing an at-home test for COVID-19 is now available. This is not the case. This EUA applies to the testing of a sample collected form the patient’s nose using a designated self-collection kit that contains nasal swabs and saline. Users must mail in their sample in an insulated package to a LabCorp for testing.

This product will be made available in the coming weeks in most states with a doctor’s order. Of note, due to sterility concerns and cross reactivity to inherent genetic materials in cotton swabs, only the special Q-tip style cotton swaps included with the kit should be used. Other cotton swabs should not be used with this test.

For more information, read the announcement in full.

Related Articles